Skip to main content

ACP: Time-Restricted Eating May Not Aid Weight Loss, Glycemic Measures

Medically reviewed by Carmen Pope, BPharm. Last updated on April 23, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, April 23, 2024 -- Time-restricted eating (TRE) is not associated with weight loss or glycemic improvements compared with a usual eating pattern (UEP) when calories are held constant in both groups, according to a study published online April 19 in the Annals of Internal Medicine to coincide with presentation at the Internal Medicine Meeting, the annual meeting of the American College of Physicians, held from April 18 to 20 in Boston.

Nisa M. Maruthur, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the effect of TRE versus UEP on body weight in the setting of stable caloric intake. The analysis included 41 participants with obesity and prediabetes or diet-controlled diabetes who were randomly assigned (1:1) to TRE (10-hour eating window; 80 percent of calories before 1 p.m.) or UEP (≤16-hour window; ≥50 percent of calories after 5 p.m.) for 12 weeks.

The researchers found that at 12 weeks, weight decreased by 2.3 kg in the TRE group versus 2.6 kg in the UEP group. The groups did not significantly differ for change in glycemic measures. Additionally, there were no significant differences seen in waist circumference, blood pressure, or lipid levels.

"In the setting of isocaloric eating, TRE did not decrease weight or improve glucose homeostasis relative to a UEP, suggesting that any effects of TRE on weight in prior studies may be due to reductions in caloric intake," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Hypoglossal Nerve Stimulation Aids Obstructive Sleep Apnea

THURSDAY, April 18, 2024 -- Hypoglossal nerve stimulation (HGNS) helps to reduce obstructive sleep apnea (OSA) but has a decreased response in some patients, according to a study...

Weight-Related Bullying Increases With More Screen Time, Social Media Use

THURSDAY, April 18, 2024 -- Among an international sample of adolescents, there is an association of increased screen time hours and social media use with weight-related bullying...

Eli Lilly Says Zepbound Can Ease Obstructive Sleep Apnea

WEDNESDAY, April 17, 2024 -- Eli Lilly announced Wednesday that in two company trials, Zepbound was found to ease sleep apnea in adults with obesity. First approved to treat...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.